Radiotherapy & Oncology
Volume 91, Issue 1 , Pages 49-53 , April 2009

The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer

  • Lindy A. Diepenmaat

      Affiliations

    • Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
  • ,
  • Maurice J.C. van der Sangen

      Affiliations

    • Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands
  • ,
  • Lonneke V. van de Poll-Franse

      Affiliations

    • Eindhoven Cancer Registry, Eindhoven, The Netherlands
    • CoRPS – Center of Research on Psychology in Somatic Diseases, Department of Medical Psychology, Tilburg University, The Netherlands
  • ,
  • Mike W.P.M. van Beek

      Affiliations

    • Regional Institute of Pathology (PAMM), Eindhoven, The Netherlands
  • ,
  • Charles L.H. van Berlo

      Affiliations

    • Department of Surgery, VieCuri Medical Centre, Venlo, The Netherlands
  • ,
  • Ernest J.T. Luiten

      Affiliations

    • Department of Surgery, St Anna Hospital, Geldrop, The Netherlands
  • ,
  • Grard A.P. Nieuwenhuijzen

      Affiliations

    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
  • ,
  • Adri C. Voogd

      Affiliations

    • Department of Epidemiology, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

Received 28 April 2008 ,Revised 10 September 2008 ,Accepted 23 September 2008.

References 

  1. The world Health Organization histological typing of breast tumors-Second ed. The World Organization. Am J Clin Pathol 1982;78:806–816.
  2. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the national surgical adjuvant breast project (protocol no4). Cancer. 1975;36:1–85
  3. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231–273
  4. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3:467–488
  5. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113–120
  6. Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg. 1995;222:549–559discussion 559-61
  7. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer. 1994;73:1673–1677
  8. Moore MM, Borossa G, Imbrie JZ, Fechner RE, Harvey JA, Slingluff CL, et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg. 2000;231:877–882
  9. Peiro G, Bornstein BA, Connolly JL, et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49–54
  10. Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ. Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg. 1995;82:1364–1366
  11. Warneke J, Berger R, Johnson C, Stea D, Villar H. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg. 1996;172:496–500
  12. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–550
  13. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the national cancer data base. Ann Surg. 2005;242:281–289
  14. van den Broek N, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, Nieuwenhuijzen GA, Voogd AC. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat. 2007;105:63–68
  15. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688–1697
  16. Bontenbal M, Nortier JW, Beex LV, Bakker P, Hupperets PS, Nooij MA, et al. Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for medical oncology. Ned Tijdschr Geneeskd. 2000;144:984–989
  17. Goldhirsch A, Glick JH, Gelber RD, Senn HJ. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst. 1998;90:1601–1608
  18. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001;19:3817–3827.
  19. du Toit RS, Locker AP, Ellis IO, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251–257
  20. Hussien M, Lioe TF, Finnegan J, Spence RA. Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23–35
  21. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247–253
  22. Hooning MJ, Aleman BM, van Rosmalen AJ, et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64:1081–1091

PII: S0167-8140(08)00513-6

doi: 10.1016/j.radonc.2008.09.012

Radiotherapy & Oncology
Volume 91, Issue 1 , Pages 49-53 , April 2009